fibrinogen has been researched along with Demyelinating Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeLuca, GC; Esiri, MM; Jacobs, B; Palace, J; Perera, R; Yates, RL | 1 |
| Bongarzone, ER; Elackattu, V; Givogri, MI; Hebert, AK; Lipton, HL; Lu, QR; Marshall, J; Marshall, MS; Moyano, AL; Pituch, KC; Rapolti, DI; Reiter, CR; Son, KN; Steplowski, J; Ulloa, V; Wang, H | 1 |
| Akassoglou, K; Baeten, KM; Bedard, C; Chan, JP; Charo, IF; Degen, JL; Lassmann, H; Machado, MR; Meyer-Franke, A; Murray, SG; Petersen, MA; Prod'homme, T; Rios Coronado, PE; Ryu, JK; Vagena, E; Zamvil, SS | 1 |
| Capello, E; Cavalla, P; Condello, C; Giordana, MT; Lorenzatti, M; Mancardi, GL; Masera, S; Mattioda, A; Merola, A; Mutani, R; Tribolo, A; Vercellino, M | 1 |
| Akassoglou, K; Degen, JL; Kombrinck, KW; Strickland, S | 1 |
| Gessain, A; Gout, O; Hauw, JJ; Ozden, S; Seilhean, D | 1 |
6 other study(ies) available for fibrinogen and Demyelinating Diseases
| Article | Year |
|---|---|
Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Demyelinating Diseases; Female; Fibrin; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Motor Cortex; Multiple Sclerosis, Chronic Progressive; Nerve Degeneration; Plasminogen Activator Inhibitor 1 | 2017 |
microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating Disease.
Topics: Animals; Biomarkers; Cardiovirus Infections; Cell Line; Cholesterol; Cytokines; Demyelinating Diseases; Disease Models, Animal; Female; Fibrinogen; Gene Expression Regulation; Inflammation Mediators; Lipid Metabolism; Mice; Microglia; MicroRNAs; Rats; RNA Interference; Theilovirus; Viral Load | 2018 |
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
Topics: Adaptive Immunity; Animals; Antigen Presentation; Autoimmunity; Blood-Brain Barrier; Brain; CD11b Antigen; Cell Proliferation; Chemokine CCL2; Chemokine CXCL10; Chemokines; CX3C Chemokine Receptor 1; Demyelinating Diseases; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Fibrin; Fibrinogen; Flow Cytometry; Gene Expression Profiling; Genes, MHC Class II; Homeodomain Proteins; Immunohistochemistry; Macrophages; Mice; Mice, Knockout; Microglia; Myelin-Oligodendrocyte Glycoprotein; Rats; Receptors, Antigen, T-Cell; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Th1 Cells | 2015 |
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Antigens, CD; Brain; Demyelinating Diseases; Female; Fibrinogen; HLA-DR Antigens; Humans; Inflammation; Male; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroglia; Neurons; Staining and Labeling | 2009 |
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
Topics: Animals; Axons; Blood Coagulation; Demyelinating Diseases; Extracellular Matrix; Fibrin; Fibrinogen; Fibrinolysis; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Denervation; Muscle, Skeletal; Nerve Degeneration; Plasminogen; Schwann Cells; Sciatic Nerve; Tissue Plasminogen Activator | 2000 |
Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient.
Topics: Adult; Apoptosis; Astrocytes; Blood Transfusion; Blood-Brain Barrier; Demyelinating Diseases; Fibrinogen; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Male; Paraparesis, Tropical Spastic | 2002 |